Mark E. Dunlap

6.1k total citations · 1 hit paper
70 papers, 3.0k citations indexed

About

Mark E. Dunlap is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Mark E. Dunlap has authored 70 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Cardiology and Cardiovascular Medicine, 15 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Mark E. Dunlap's work include Heart Failure Treatment and Management (27 papers), Cardiovascular Function and Risk Factors (17 papers) and Cardiac pacing and defibrillation studies (14 papers). Mark E. Dunlap is often cited by papers focused on Heart Failure Treatment and Management (27 papers), Cardiovascular Function and Risk Factors (17 papers) and Cardiac pacing and defibrillation studies (14 papers). Mark E. Dunlap collaborates with scholars based in United States, Canada and United Kingdom. Mark E. Dunlap's co-authors include Steve Bibevski, Marc A. Pfeffer, Paul A. Sobotka, Jeffrey P. Cohen, Gary F. Mitchell, Joseph M. Hellerstein, J. Malcolm O. Arnold, Christopher B. Granger, Bertil Olofsson and Karl Swedberg and has published in prestigious journals such as Circulation, Journal of Neuroscience and Journal of the American College of Cardiology.

In The Last Decade

Mark E. Dunlap

69 papers receiving 2.9k citations

Hit Papers

MAD skills 2009 2026 2014 2020 2009 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. MAD skills
    2009 296 citations Mark E. Dunlap et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark E. Dunlap United States 29 2.1k 523 318 318 270 70 3.0k
Claudio Brunelli Italy 30 1.5k 0.7× 423 0.8× 530 1.7× 159 0.5× 492 1.8× 131 3.1k
Shûichi Ichikawa Japan 32 1.2k 0.6× 373 0.7× 501 1.6× 599 1.9× 195 0.7× 193 2.8k
George Louridas Greece 26 1.6k 0.8× 744 1.4× 1.0k 3.2× 82 0.3× 255 0.9× 106 2.8k
Kuan‐Cheng Chang Taiwan 23 955 0.5× 253 0.5× 529 1.7× 125 0.4× 410 1.5× 143 2.3k
Gurpreet Singh Wander India 28 922 0.4× 154 0.3× 407 1.3× 352 1.1× 375 1.4× 163 2.8k
Eric R. Gross United States 35 926 0.4× 173 0.3× 357 1.1× 281 0.9× 1.2k 4.6× 76 4.1k
Katerina Κ. Naka Greece 33 2.1k 1.0× 752 1.4× 1.1k 3.6× 553 1.7× 379 1.4× 192 4.2k
Rik Willems Belgium 38 4.5k 2.1× 422 0.8× 594 1.9× 50 0.2× 511 1.9× 277 5.3k
Thomas G. Coleman United States 23 938 0.4× 413 0.8× 323 1.0× 467 1.5× 340 1.3× 59 2.5k
João Morais Portugal 34 3.2k 1.5× 205 0.4× 903 2.8× 149 0.5× 112 0.4× 180 4.3k

Countries citing papers authored by Mark E. Dunlap

Since Specialization
Citations

This map shows the geographic impact of Mark E. Dunlap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Dunlap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Dunlap more than expected).

Fields of papers citing papers by Mark E. Dunlap

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Dunlap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Dunlap. The network helps show where Mark E. Dunlap may publish in the future.

Co-authorship network of co-authors of Mark E. Dunlap

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Dunlap. A scholar is included among the top collaborators of Mark E. Dunlap based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Dunlap. Mark E. Dunlap is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bradley, T. Douglas, Alexander G. Logan, Geraldo Lorenzi‐Filho, et al.. (2023). Adaptive servo-ventilation for sleep-disordered breathing in patients with heart failure with reduced ejection fraction (ADVENT-HF): a multicentre, multinational, parallel-group, open-label, phase 3 randomised controlled trial. The Lancet Respiratory Medicine. 12(2). 153–166. 40 indexed citations
2.
Fudim, Marat, Piotr Ponikowski, Daniel Burkhoff, et al.. (2021). Splanchnic nerve modulation in heart failure: mechanistic overview, initial clinical experience, and safety considerations. European Journal of Heart Failure. 23(7). 1076–1084. 29 indexed citations
3.
Dunlap, Mark E.. (2021). “I've Had a Good Run”. Journal of Cardiac Failure. 27(11). 1290–1290. 2 indexed citations
4.
Pasala, Tilak, Florian Rader, Theophilus Owan, et al.. (2016). CENTRAL INDICES OF AORTIC STIFFNESS PREDICT SEVERITY AND BURDEN OF CORONARY ARTERY DISEASE BEYOND TRADITIONAL RISK MODELS. Journal of the American College of Cardiology. 67(13). 2016–2016. 1 indexed citations
5.
6.
Bhardwaj, Anju & Mark E. Dunlap. (2015). Autonomic Dysregulation as a Therapeutic Target for Acute HF. Current Treatment Options in Cardiovascular Medicine. 17(10). 403–403. 2 indexed citations
7.
Burchell, Amy E., Paul A. Sobotka, Emma C. Hart, Angus K. Nightingale, & Mark E. Dunlap. (2013). Chemohypersensitivity and Autonomic Modulation of Venous Capacitance in the Pathophysiology of Acute Decompensated Heart Failure. Current Heart Failure Reports. 10(2). 139–146. 24 indexed citations
8.
Forman, Daniel E., Jerome L. Fleg, Dalane W. Kitzman, et al.. (2012). 6-Min Walk Test Provides Prognostic Utility Comparable to Cardiopulmonary Exercise Testing in Ambulatory Outpatients With Systolic Heart Failure. Journal of the American College of Cardiology. 60(25). 2653–2661. 145 indexed citations
9.
Krum, Henry, Markus P. Schlaich, Paul A. Sobotka, et al.. (2012). TCT-12 Long-term Follow-up of Catheter-based Renal Denervation For Resistant Hypertension Confirms Durable Blood Pressure Reduction. Journal of the American College of Cardiology. 60(17). B3–B3. 15 indexed citations
10.
Dunlap, Mark E., et al.. (2012). Anemia and Iron Deficiency in Heart Failure. Current Heart Failure Reports. 9(4). 319–327. 14 indexed citations
11.
12.
Desai, Akshay S., Karl Swedberg, John J.V. McMurray, et al.. (2007). Incidence and Predictors of Hyperkalemia in Patients With Heart Failure. Journal of the American College of Cardiology. 50(20). 1959–1966. 129 indexed citations
13.
Lewis, Eldrin F., Gervasio A. Lamas, Eileen O’Meara, et al.. (2006). Characterization of Health-Related Quality of Life in Heart Failure Patients with Preserved Versus Low Ejection Fraction in CHARM. European Journal of Heart Failure. 9(1). 83–91. 179 indexed citations
14.
O’Meara, Eileen, Eldrin F. Lewis, C. B. Granger, et al.. (2005). Patient Perception of the Effect of Treatment with Candesartan in Heart Failure. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. European Journal of Heart Failure. 7(4). 650–656. 21 indexed citations
15.
Mitchell, Gary F., J. Malcolm O. Arnold, Mark E. Dunlap, et al.. (2005). Pulsatile Hemodynamic Effects of Candesartan in Patients with Chronic Heart Failure: The CHARM Program. European Journal of Heart Failure. 8(2). 191–197. 22 indexed citations
16.
Dunlap, Mark E., et al.. (2005). Management of heart failure with pulmonary hypertension. Current Cardiology Reports. 7(3). 196–203. 1 indexed citations
17.
Boxer, Rebecca S. & Mark E. Dunlap. (2005). Aldosterone antagonists in the treatment and prevention of heart failure. Current Treatment Options in Cardiovascular Medicine. 7(6). 431–436. 2 indexed citations
18.
Ibrahim, Osama A. & Mark E. Dunlap. (2005). Combination pharmacologic therapies for heart failure: What next after angiotensin-converting enzyme inhibitors and beta-blockers?. Current Heart Failure Reports. 2(2). 89–93. 2 indexed citations
19.
20.
Dunlap, Mark E., Steve Bibevski, Terrone L. Rosenberry, & Paul Ernsberger. (2003). Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity. American Journal of Physiology-Heart and Circulatory Physiology. 285(4). H1632–H1640. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudio Brunelli Breakdown of academic impact, for papers by Shûichi Ichikawa Breakdown of academic impact, for papers by George Louridas Breakdown of academic impact, for papers by Kuan‐Cheng Chang Breakdown of academic impact, for papers by Gurpreet Singh Wander Breakdown of academic impact, for papers by Eric R. Gross Breakdown of academic impact, for papers by Katerina Κ. Naka Breakdown of academic impact, for papers by Rik Willems Breakdown of academic impact, for papers by Thomas G. Coleman Breakdown of academic impact, for papers by João Morais
Rankless by CCL
2026